A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)

Clinical trial NCT07172516 · RECRUITING

Trial details

NCT number: NCT07172516
Sponsor: Xenon Pharmaceuticals Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Bipolar Disorder Bipolar Depression Bipolar I Disorder Bipolar II Disorder

Start date: 2025-08-08
Primary completion: 2028-06-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.